Skip to main content
NEWLAND PHARMACEUTICAL CO., LTD logo

NEWLAND PHARMACEUTICAL CO., LTD — Investor Relations & Filings

Ticker · 301277 ISIN · CNE1000065K2 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 481 across all filing types
Latest filing 2025-12-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301277

About NEWLAND PHARMACEUTICAL CO., LTD

https://www.newlandpharma.com

Newland Pharmaceutical Co., Ltd. is a specialized enterprise engaged in the research, development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs) and high-quality chemical intermediates. The company focuses on a broad spectrum of therapeutic categories, including cardiovascular, anti-infective, and metabolic health solutions. Operating with a commitment to rigorous quality control, its production facilities are designed to meet international Good Manufacturing Practice (GMP) standards. Newland Pharmaceutical prioritizes technological innovation and chemical synthesis optimization to deliver reliable pharmaceutical components. Its core operations involve the large-scale production of complex molecules, supporting the supply chains of healthcare providers and pharmaceutical formulators worldwide through a focus on technical excellence and regulatory compliance.

Recent filings

Filing Released Lang Actions
内幕信息知情人登记备案管理制度
Regulatory Filings Classification · 95% confidence The document is a detailed internal management system for insider information registration and confidentiality for a company, including definitions, responsibilities, procedures, and legal compliance related to insider information. It does not contain financial statements, earnings data, or any report of financial performance. It is a regulatory compliance document outlining internal governance and control measures related to insider information. It is not an announcement, transcript, or report of financial results or corporate actions. It fits best under Regulatory Filings (RNS) as a compliance and governance-related regulatory document that does not fit other specific categories.
2025-12-08 Chinese
年报信息披露重大差错责任追究制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled 'Annual Report Information Disclosure Major Error Responsibility Pursuit System' for a company. It outlines the principles, standards, and procedures for identifying and handling major errors in annual report disclosures, including financial reporting errors, responsibilities of company personnel, and disciplinary measures. It references annual reports and regulatory requirements but does not contain actual financial statements or financial performance data. It is not an annual report itself, nor an announcement of a report, but rather a governance and compliance policy document related to annual report disclosures. Therefore, it fits best under Governance Information (CGR), which covers internal rules and governance practices related to reporting and disclosure.
2025-12-08 Chinese
累积投票制实施细则
Governance Information Classification · 95% confidence The document is titled as "累积投票制实施细则" which translates to "Cumulative Voting Implementation Rules" for the election of directors at 新天地药业股份有限公司. It details the procedures, principles, and rules for cumulative voting in director elections, including voting rights, election principles, and special procedures. There is no financial data, no mention of financial results, no regulatory filings, no announcements of votes or dividends, and no management or board changes. It is a governance-related document outlining internal rules and procedures for shareholder voting and director elections. Therefore, it fits best under Governance Information (CGR). The document length is 2261 characters, which is not a brief announcement but a detailed procedural document, supporting the CGR classification.
2025-12-08 Chinese
市值管理制度
Governance Information Classification · 95% confidence The document is titled '市值管理制度' (Market Value Management System) and outlines the company's policies, principles, organizational responsibilities, and procedures related to managing and enhancing the company's market value. It includes detailed governance and operational guidelines but does not contain financial statements, earnings data, or regulatory filings. It is a formal internal policy document rather than a report or announcement of financial results or corporate actions. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is also not a presentation, call transcript, or legal proceeding report. Given the nature of the document as a governance and management policy, the closest fitting category is Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is substantive and detailed, supporting a high confidence classification as CGR.
2025-12-08 Chinese
会计师事务所选聘管理制度
Audit Report / Information Classification · 95% confidence The document is titled '会计师事务所选聘管理制度' which translates to 'Management System for the Selection of Accounting Firms'. It details the procedures, requirements, and regulations for selecting, appointing, and managing the accounting firms that audit the company's financial reports. It includes references to audit committees, board and shareholder approvals, audit quality standards, and supervisory responsibilities. There is no actual financial data, audit reports, or financial statements included. Instead, it is a governance and procedural document related to audit firm selection and oversight. This fits best under 'Audit Report / Information (AR)' as it pertains to audit-related policies and procedures but is not a full annual report or audit report itself. It is not a regulatory filing or announcement, nor a management or board change notice. Therefore, the classification is AR with high confidence. FY 2024
2025-12-08 Chinese
对外投资管理制度
Governance Information Classification · 95% confidence The document is titled '对外投资管理制度' which translates to 'External Investment Management System' and contains detailed internal policies and procedures for managing the company's external investments. It includes governance, approval processes, risk management, financial management, auditing, and disclosure requirements related to investments. There is no indication that this is a financial report, earnings release, or regulatory filing announcing a report. It is a governance and management policy document outlining internal rules and procedures for investment activities. Therefore, it fits best under Governance Information (CGR). The document length (7963 characters) and content confirm it is a substantive policy document, not a brief announcement or certification.
2025-12-08 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.